ChemistDirect.co.uk

Founded in 2007 in Oldbury, UK, Chemist Direct operates as an online pharmacy providing health products. The company was acquired by Pharmacy2U on July 4, 2016, for GBP 40 million, which has allowed Pharmacy2U to expand its business.Chemist Direct operates as an online pharmacy offering a diverse range of products primarily focused on over-the-counter medications, health supplements, and personal care items. Among their core offerings are pain relief medications such as Paracetamol and Eroxon® Stimgel for erectile dysfunction, as well as health-focused products like SlimFast meal replacement shakes. The company also provides oral care solutions, including the Oral-B iO6 electric toothbrush. These products are designed to cater to a wide customer base, including individuals seeking quick relief from ailments, those managing weight, and men seeking solutions for erectile dysfunction.Chemist Direct generates revenue through direct-to-consumer sales of their health and wellness products, complemented by subscription services that facilitate repeat deliveries. Standard pricing structures include single item purchases and subscription-based models, which offer convenience for customers needing regular supplies of everyday essentials. Key products, such as VIAGRA Connect and Optrex Infected Eye Drops, exemplify the company's strategic focus on high-demand health solutions. The company capitalizes on its competitive edge by providing free UK delivery for orders over GBP 35, enhancing customer retention and encouraging larger transactions.Following the acquisition by Pharmacy2U in July 2016, which was aimed at enhancing their service offerings, Chemist Direct is expected to leverage this strategic partnership to expand its product lines and service capabilities. Future growth initiatives may include the introduction of new products, although specific details have not been disclosed. The company is also likely to explore opportunities to enter new geographic markets in alignment with Pharmacy2U's expansion strategy.

1. Series B

   Jul 5, 2013

   Amount

   $10M

   Investors

   Locked